Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development.

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Sited in the Lebanon, IN, the pharma giant will research new ways to produce medicines and to scale up production.

The initiative is expected to optimise processes, boost trial medicine capacity, and reduce both costs and environmental ...

LEBANON, Ind. (WFFT) — Eli Lilly and Company announced another $4.5 billion investment in Lebanon’s LEAP Research and ...

Eli Lilly and Co. (Indianapolis, Ind.) announced a $4.5-billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...

Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the states controversial LEAP ...

The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to more than $13 billion, ...

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...

INDIANAPOLIS - Eli Lilly and Company announced Wednesday that it will invest $4.5 billion to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development in ...

The company’s first two investments in the district were for a manufacturing site. The new site will focus on research, but ...